Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jan Fleckner

Showing results (31-40 of 33) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 33 results.
Elife|October 3, 2024
Evaluation of Gremlin-1 as a therapeutic target in metabolic dysfunction-associated steatohepatitisPaul Horn, Jenny Norlin, Kasper Almholt, et al.
JHEP Reports : Innovation in Hepatology|May 1, 2023
Hepatocyte mARC1 promotes fatty liver diseaseLara C Lewis, Lingyan Chen, L Shahul Hameed, et al.
The New England Journal of Medicine|December 27, 2018
Diagnostic Utility of Exome Sequencing for Kidney DiseaseEmily E Groopman, Maddalena Marasa, Sophia Cameron-Christie, et al.
Pageof 4

Showing results (31-40 of 33) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 33 results.
Elife|October 3, 2024
Evaluation of Gremlin-1 as a therapeutic target in metabolic dysfunction-associated steatohepatitisPaul Horn, Jenny Norlin, Kasper Almholt, et al.
JHEP Reports : Innovation in Hepatology|May 1, 2023
Hepatocyte mARC1 promotes fatty liver diseaseLara C Lewis, Lingyan Chen, L Shahul Hameed, et al.
The New England Journal of Medicine|December 27, 2018
Diagnostic Utility of Exome Sequencing for Kidney DiseaseEmily E Groopman, Maddalena Marasa, Sophia Cameron-Christie, et al.
Pageof 4